Seattle Genetics Headquarters is located at Bothell’s Cascade Business Park. At the building which hosts the Company’s offices, there is a sculpture of a human antibody which is made of Lego bricks. Seattle Genetics was established in 1998 with the main responsibility of carrying research, deploying, as well as packaging of antibody drugs that treat cancer. Seattle group has been growing since its foundation and has become big, and the hope of the world in the development of cancer therapy through their antibody drugs. The pharmaceutical group has is founded on a very strong plan which the management’s anchor.
Seattle Genetics has been ranked as one of the largest biotech firms in Washington, with a market value of about $10billion offering employment to more than 900 individuals in the United States of America. The organization has been working hard to ensure that it has it is among the companies which transit from being a biotech firm to one of the largest pharmaceutical companies in the world. Seattle focuses mainly on cancer drug research, as well as marketing of the drug and has plans to expand its services by employing 200 staff this year. The organization has developed one of the most effective drugs; Adcetris which is known to treat Hodgins Lymphoma. According to the President of the group; Clay Seattle the company is becoming an International multi product oncology firm. Mr. Clay talked about the upcoming drugs which will soon be available in the market. The new drugs are a clear indication of his desire to create a big company to take care of the cancer patients.
Clay Siegall is the co-founder, President, Chief executive Officer, and the Chairman of Seattle Genetics. After his High School graduation, he attended The University of Maryland where he graduated with a B.S in Zoology and later a Ph.D. from George Washington University. Dr. Clay co-founded Seattle in 1998 and since its inception, he has led the firm to greater levels in the development of antibody drug Conjugate. He has also been in the forefront of connecting the organization with other buyers including; Genentech, Pfizer, Bayer among others. Dr. Clay Siegall believes that Seattle Genetics has the ability to find cancer therapy through rigorous study, drug advancement, as well as marketing of the drug. The doctor and medical l researcher believe that if one is to be successful hard work is very essential, passion of what one is doing and being focused.